On PAR with aPC to target inflammasomes

Steven R Lentz¹

Affiliations

PMID: 29242206
DOI: 10.1182/blood-2017-09-806307

Free article

Comment

On PAR with aPC to target inflammasomes

Steven R Lentz. Blood. 2017.

Free article

. 2017 Dec 14;130(24):2579-2581.

doi: 10.1182/blood-2017-09-806307.

Author

Steven R Lentz¹

Affiliation

¹ UNIVERSITY OF IOWA.

PMID: 29242206
DOI: 10.1182/blood-2017-09-806307

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Comment on

Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.
Nazir S, Gadi I, Al-Dabet MM, Elwakiel A, Kohli S, Ghosh S, Manoharan J, Ranjan S, Bock F, Braun-Dullaeus RC, Esmon CT, Huber TB, Camerer E, Dockendorff C, Griffin JH, Isermann B, Shahzad K. Nazir S, et al. Blood. 2017 Dec 14;130(24):2664-2677. doi: 10.1182/blood-2017-05-782102. Epub 2017 Sep 7. Blood. 2017. PMID: 28882883 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

On PAR with aPC to target inflammasomes

Affiliation

On PAR with aPC to target inflammasomes

Author

Affiliation

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources